There was no significant difference in the use of aspirin, beta-blockers, and ACE inhibitors in patients with or without PAD, nor a difference in the prescription rate of these medications after discharge, with the exception of statins, where slightly lower prescription at day 30 may indicate poorer treatment adherence in the PAD group. The gene discussed is ACE; the disease is peripheral arterial disease.